Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Dina Jacobs, M.D.

Associate Professor of Neurology at the Hospital of the University of Pennsylvania
Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Medical monitor , Penn Medicine Community Vaccine Clinics
Clinical Director, Center for Neuroinflammation and Experimental Therapeutics, Penn Medicine
Department: Neurology

Contact information
Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Office: (215) 662-3647
Fax: (215) 349-5579
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
University of Pennsylvania, 1996.
Post-Graduate Training
Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.
American Board of Psychiatry and Neurology , 2001.
American Board of Psychiatry and Neurology; Recertification, 2011.
American Board of Psychiatry and Neurology; Recertification, 2022.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M, Zuroff L, Bennett J, von Budingen HC, Carruthers R, Edwards K, Fallis R, Giacomini P, Greenberg B, Hafler D, Ionete C, Kaunzner U, Lock C, Longbrake E, Pardo G, Piehl F, Weber M, Ziemssen T, Jacobs D, Gelfand J, Cross A, Cameron B, Musch B, Winger R, Jia X, Harp C, Herman A, Bar-Or A.: Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. PNAS 120(3): e2207291120, Jan 2023.

Gandelman S, Thebault S, Zuroff L, Pileggi C, Markowitz C, Brandstadter R, Jacobs D: Neuroinvasive West Nile Virus in Association with Ocrelizumab Use in Multiple Sclerosis. ACTRIMS, San Diego, CA 2023.

Korin Miller: ‘Today I Was Me’: Why Christina Applegate Went Barefoot During Her Hollywood Walk of Fame Ceremony. Self Magazine Nov 2022 Notes:

Weinstein S, Reilly E, Garland N, Zimmerman V, Jacobs D: Impact of a Virtual Wellness Program on Quality of Life Measures for Patients Living with Multiple Sclerosis During the COVID-19 Pandemic. International Journal MS Care 24(6): 282-286, Nov-Dec 2022.

Downey K, Jacobs D: MS armamentarium aids clinicians, patients during pregnancy planning. Healio Oct 2022 Notes: video:

Zuroff L, Rezk A, Shinoda K, Espinoza D, Elyahu Y, Zhang B, Chen A, Shinohara R, Jacobs D, Alcalay R, Tropea T, Chen-Plotkin A, Monsonego A, Li R, Bar-Or A.: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age. EBioMedicine 82: 104179, Aug 2022.

Mattay R, Davtyan K, Rudie J, Govind M, Jacobs D, Schindler M, Loevner L, Schnall M, Bilello M, Mamourian A, and Cook T.: Economic impact of selective use of contrast for routine follow up MRI of patients with multiple sclerosis. Journal of Neuroimaging 32(4): 656-666, Jul 2022.

Ostrem B, Anderson A, Conway S, Healy B, Oh J, Jacobs D, Dobson R, Graham E, Sadovnick D, Zimmerman V, Liu Y, Bove R, Houtchens M.: Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. Multiple Sclerosis Journal – Experimental, Translational, Clinical 8(2): 20552173221104918, Jun 2022.

Gandelman S, Stein L, Jacobs D: Improving time to ocrelizumab initiation in multiple sclerosis by accelerating lab acquisition Penn Neurology Resident Poster Session Capstone Seminar 2022.

Anderson A, Jacobs D, Ciplea A, Brandtadter R, Fabian M, Kakara M, Krysko KM, Longbrake E, Reopvic P, Romeo A, West T, Hellwig K, and Bove R. : Ocrelizumab in postpartum women with multiple sclerosis: low transfer into breast milk and reassuring infant development in a multicenter cohort. ACTRIMS 2022, West Palm Beach, FL. 2022.

back to top
Last updated: 01/31/2023
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration